◀ Back to EGF
EGF — IRS1
Pathways - manually collected, often from reviews:
Text-mined interactions from Literome
Lingohr et al., Diabetes 2002
(MAP Kinase Signaling System) :
Neither
IRS-1 nor IRS-2 overexpression
induced a beta-cell proliferative response to
TGF-alpha/EGF
Gogg et al., J Biol Chem 2002
(Insulin Resistance) :
EGF increased the tyrosine phosphorylation of several proteins ( the EGF receptor, insulin receptor substrate
(IRS)-1 , IRS-2, and Grb2 associated binder 1 ), whereas Shc and Gab2 were only weakly and inconsistently phosphorylated ... Both insulin and
EGF increase the tyrosine phosphorylation and activation of
IRS-1 and IRS-2, whereas EGF is also capable of activating additional PI 3-kinase pools and, thus, can augment the downstream signaling of insulin in insulin-resistant states like Type 2 diabetes
Hardy et al., Endocrinology 1995
:
EGF did not
stimulate tyrosine phosphorylation of the insulin receptor or
insulin receptor substrate-1
Burgaud et al., Exp Cell Res 1996
(Cell Transformation, Viral) :
The mutant IGF-I receptors are activated ( tyrosyl phosphorylation of
IRS-I ) in
response to
EGF